AU2002338436A1 - Hcg formulation - Google Patents

Hcg formulation

Info

Publication number: AU2002338436A1
Authority: AU; Australia
Prior art keywords: hcg formulation; hcg; formulation
Prior art date: 2001-04-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002338436A

Inventor

Hernan F. Acevedo

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-25

Filing date

2002-04-25

Publication date

2002-11-05

2002-04-25 Application filed by Individual filed Critical Individual

2002-11-05 Publication of AU2002338436A1 publication Critical patent/AU2002338436A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Reproductive Health (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002338436A 2001-04-25 2002-04-25 Hcg formulation Abandoned AU2002338436A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US28593901P	2001-04-25	2001-04-25
US60/285,939		2001-04-25
PCT/US2002/013269 WO2002085311A2 (en)	2001-04-25	2002-04-25	Hcg formulation

Publications (1)

Publication Number	Publication Date
AU2002338436A1 true AU2002338436A1 (en)	2002-11-05

Family

ID=23096335

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002338436A Abandoned AU2002338436A1 (en)	2001-04-25	2002-04-25	Hcg formulation

Country Status (6)

Country	Link
EP (1)	EP1390053A2 (en)
JP (1)	JP2004529147A (en)
CN (1)	CN1512890A (en)
AU (1)	AU2002338436A1 (en)
WO (1)	WO2002085311A2 (en)
ZA (1)	ZA200309136B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005077404A1 (en)	2004-02-13	2005-08-25	Stem Cell Therapeutics Corp.	Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
WO2007092252A2 (en) *	2006-02-03	2007-08-16	Modigene Inc	Long-acting polypeptides and methods of producing same
US20140113860A1 (en)	2006-02-03	2014-04-24	Prolor Biotech Ltd.	Long-acting polypeptides and methods of producing and administering same
US10351615B2 (en)	2006-02-03	2019-07-16	Opko Biologics Ltd.	Methods of treatment with long-acting growth hormone
US8048849B2 (en)	2006-02-03	2011-11-01	Modigene, Inc.	Long-acting polypeptides and methods of producing same
US20150038413A1 (en)	2006-02-03	2015-02-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US9249407B2 (en)	2006-02-03	2016-02-02	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US10221228B2 (en)	2006-02-03	2019-03-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US8946155B2 (en)	2006-02-03	2015-02-03	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US20110197294A1 (en) *	2008-06-04	2011-08-11	Gottlieb Roberta A	Compositions and methods for restoring mitochondrial electron transfer function
US9663778B2 (en)	2009-07-09	2017-05-30	OPKO Biologies Ltd.	Long-acting coagulation factors and methods of producing same
US12203113B2 (en)	2009-07-09	2025-01-21	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
DE102009056871A1 (en) *	2009-12-03	2011-06-22	Novartis AG, 4056	Vaccine adjuvants and improved methods of making the same
RU2463066C1 (en) *	2011-08-19	2012-10-10	Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации	Prolonged release pharmacological antimicrobial composition
PE20142405A1 (en)	2012-04-19	2015-01-25	Opko Biolog Ltd	LONG-ACTING OXYTOMODULIN VARIANTS AND METHODS OF PRODUCING THEM
EP2922867B1 (en)	2012-11-20	2021-07-21	OPKO Biologics Ltd.	Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
US20150065426A1 (en) *	2013-08-27	2015-03-05	Professional Compounding Centers Of America	Testosterone Booster Transdermal Compositions
US20150158926A1 (en)	2013-10-21	2015-06-11	Opko Biologics, Ltd.	Long-acting polypeptides and methods of producing and administering same
PH12017501089B1 (en)	2014-12-10	2022-06-22	Opko Biologics Ltd	Methods of producing long acting ctp-modified growth hormone polypeptides
US9895313B2 (en)	2015-03-03	2018-02-20	Cureport, Inc.	Combination liposomal pharmaceutical formulations
CN107530291A (en)	2015-03-03	2018-01-02	奎尔波特股份有限公司	Double heavy duty liposomal pharmaceutical preparations
AU2016280867B2 (en)	2015-06-19	2020-02-27	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
KR102618424B1 (en)	2016-07-11	2023-12-26	옵코 바이오로직스 리미티드	Persistent coagulation factor VII and method for producing the same
CN117959415A (en)	2016-09-13	2024-05-03	阿勒根公司	Non-protein Clostridial toxin compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4691006A (en) *	1983-03-04	1987-09-01	Ohio State University	Antigenic modification of polypeptides
US5811390A (en) *	1995-08-22	1998-09-22	Metatron, Inc.	Use of beta HCG for the control of retroviral infection

2002
- 2002-04-25 CN CNA028109368A patent/CN1512890A/en active Pending
- 2002-04-25 AU AU2002338436A patent/AU2002338436A1/en not_active Abandoned
- 2002-04-25 JP JP2002582887A patent/JP2004529147A/en active Pending
- 2002-04-25 EP EP02764353A patent/EP1390053A2/en not_active Withdrawn
- 2002-04-25 WO PCT/US2002/013269 patent/WO2002085311A2/en not_active Ceased
2003
- 2003-11-25 ZA ZA200309136A patent/ZA200309136B/en unknown

Also Published As

Publication number	Publication date
CN1512890A (en)	2004-07-14
WO2002085311A2 (en)	2002-10-31
JP2004529147A (en)	2004-09-24
WO2002085311A3 (en)	2003-08-21
ZA200309136B (en)	2005-10-26
EP1390053A2 (en)	2004-02-25

Publication	Publication Date	Title
AU2002338436A1 (en)	2002-11-05	Hcg formulation
AU2002313565A1 (en)	2003-03-18	Putter-heads
AU2002315122A1 (en)	2003-03-03	Self-guyed structures
AU2003226487A1 (en)	2003-09-22	Formulation
AU2002309475A1 (en)	2003-03-27	Esmolol formulation
IL146737A0 (en)	2002-07-25	Carotenoid formulation
AU2002361985A1 (en)	2003-06-17	Microemulsifier
AUPR843001A0 (en)	2001-11-15	Hasplock
AU2002313073A1 (en)	2002-12-03	Phytocystatin
AU2002329433A1 (en)	2003-05-06	Formulation
AU2002300836A1 (en)	2003-06-12	Solid Formulation
AU2002343300A1 (en)	2003-05-12	Novel formulation
AU2002353664A1 (en)	2003-06-30	Routeplanner
AU2002228215A1 (en)	2002-08-28	Agrochemical formulation
AUPR454901A0 (en)	2001-05-24	Nutrient formulation
AU2002333362A1 (en)	2003-02-24	Flat structure
AUPR853301A0 (en)	2001-11-29	Various devices
AU2002249139A1 (en)	2002-08-06	Pesticidal formulation
HK1052654B (en)	2005-09-16	Rapid onset formulation
AU2002362548A1 (en)	2003-04-07	**
AU2001298048A1 (en)	2003-05-19	**
AU2002235828A1 (en)	2002-07-24	Transom-mullion structure
AU2002258273A1 (en)	2002-11-25	Drain-outlet structure
AU2002251991A1 (en)	2002-09-12	Modified square
AUPR620201A0 (en)	2001-08-02	Playmat

Legal Events

Date	Code	Title	Description
2004-02-19	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase